Athersys finishes enrolling heart attack patients for stem cell …
CLEVELAND, Ohio – Biopharmaceutical company Athersys Inc. has finished enrolling patients for a phase 1 clinical trial of its MultiStem adult stem cell therapy to treat heart attack victims. Athersys expects to begin getting results of the trial …
[Read the full article here]Related News:
Athersys finishes enrolling heart attack patients for stem cell therapy study
Athersys stem cell therapy could offer new heart attack treatment
Athersys still looking for funders of stem cell study for stroke patients